PD-1 Antibody |
24505-100ul |
SAB |
100ul |
EUR 468 |
Human IgG antibody Laboratories manufactures the anti rat pd-1 antibody reagents distributed by Genprice. The Anti Rat Pd-1 Antibody reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact rat Antibody. Other Anti products are available in stock. Specificity: Anti Category: Rat Group: Pd-1 Antibody
PD-1 / CD279 Antibody |
Abbexa |
100 ug |
EUR 661.2 |
|
PD-1 / CD279 Antibody |
Abbexa |
100 ug |
EUR 661.2 |
|
Polyclonal PD-1 Antibody |
Leading Biology |
0.1 mg |
EUR 790.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human PD-1 . This antibody is tested and proven to work in the following applications: |
Polyclonal PD-1 Antibody |
Leading Biology |
0.1 mg |
EUR 790.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human PD-1 . This antibody is tested and proven to work in the following applications: |
PD-1 Monoclonal Antibody |
SAB |
100ul |
EUR 468 |
PD-1 Monoclonal Antibody |
SAB |
100ul |
EUR 468 |
PD-1 Polyclonal Antibody |
SAB |
100ul |
EUR 302.4 |
Pd-1 Antibody information
Anti-PD-L1 Antibody |
A1454-30T |
Biovision |
each |
EUR 175.2 |
anti- PD-ECGF antibody |
FNab06264 |
FN Test |
100µg |
EUR 702 |
|
Description: Antibody raised against PD-ECGF |
Anti-PD-L1 antibody |
STJ190082 |
St John's Laboratory |
200 µl |
EUR 236.4 |
Description: Unconjugated Mouse monoclonal to PD-L1 (AS1A7) |
Anti-PD-L1 antibody |
STJ130022 |
St John's Laboratory |
50 µl |
EUR 385.2 |
Description: Programmed death-ligand 1 (PD-L1) is a 40kDa type 1 transmembrane protein that suppresses immune system. PD-L1 is expressed in hematopoietic and nonhematopoietic cells including T cells and B cells and various types of tumor cells. PD-L1 binds to its receptor Programmed death 1 (PD1). During infection or inflammation, PD1PD-L1 interaction is important for preventing autoimmunity. In tumor microenvironments, PD1-PD-L1 interaction provides an immune escape for tumor cells through cytotoxic T-cell inactivation. Expression of this gene in tumor cells is considered to be prognostic in many types of human cancers. In recent years, PDL1 has become an important biomarker and immunotherapy target for many types of malignancies. |
Anti-PD-L1 antibody |
STJ130023 |
St John's Laboratory |
50 µl |
EUR 385.2 |
Description: Programmed death-ligand 1 (PD-L1) is a 40kDa type 1 transmembrane protein that suppresses immune system. PD-L1 is expressed in hematopoietic and nonhematopoietic cells including T cells and B cells and various types of tumor cells. PD-L1 binds to its receptor Programmed death 1 (PD1). During infection or inflammation, PD1PD-L1 interaction is important for preventing autoimmunity. In tumor microenvironments, PD1-PD-L1 interaction provides an immune escape for tumor cells through cytotoxic T-cell inactivation. Expression of this gene in tumor cells is considered to be prognostic in many types of human cancers. In recent years, PDL1 has become an important biomarker and immunotherapy target for many types of malignancies. |
Anti-PD-L1 antibody |
STJ130024 |
St John's Laboratory |
50 µl |
EUR 385.2 |
Description: Programmed death-ligand 1 (PD-L1) is a 40kDa type 1 transmembrane protein that suppresses immune system. PD-L1 is expressed in hematopoietic and nonhematopoietic cells including T cells and B cells and various types of tumor cells. PD-L1 binds to its receptor Programmed death 1 (PD1). During infection or inflammation, PD1PD-L1 interaction is important for preventing autoimmunity. In tumor microenvironments, PD1-PD-L1 interaction provides an immune escape for tumor cells through cytotoxic T-cell inactivation. Expression of this gene in tumor cells is considered to be prognostic in many types of human cancers. In recent years, PDL1 has become an important biomarker and immunotherapy target for many types of malignancies. |
Anti-PD-L2 antibody |
STJ98748 |
St John's Laboratory |
200 µl |
EUR 236.4 |
Description: Rabbit polyclonal to PD-L2. |
Anti-PD-1 (Pembrolizumab) Biotinylated Antibody |
A2073-50 |
Biovision |
50 µg |
EUR 454.8 |
Anti-PD-ECGF Antibody |
A06329 |
BosterBio |
100ul |
EUR 476.4 |
Description: Rabbit Polyclonal Antibody for PD-ECGF Antibody (TYMP) detection.tested for IHC, WB in Human. |
Anti-PD-ECGF antibody |
STJ96779 |
St John's Laboratory |
200 µl |
EUR 236.4 |
Description: Rabbit polyclonal to PD-ECGF. |
PD-1 Antibody |
24505-100ul |
SAB |
100ul |
EUR 468 |
PD-1 Antibody |
24506-100ul |
SAB |
100ul |
EUR 468 |
PD-1 Antibody |
4065-002mg |
ProSci |
0.02 mg |
EUR 206.18 |
|
Description: PD-1 Antibody: Cell-mediated immune responses are initiated by T lymphocytes that are themselves stimulated by cognate peptides bound to MHC molecules on antig en-presenting cells (APC). T-cell activation is generally self-limited as activated T cells express receptors such as PD-1 (also known as PDCD-1) that mediate inhibitory signals from the APC. PD-1 can bind two different but related ligands, PDL-1 and PDL-2. Upon binding to either of these ligands, signals generated by PD-1 inhibit the activation of the immune response in the absence of "danger signals" such as LPS or other molecules associated with bacteria or other pathogens. Evidence for this is seen in PD1-null mice who exhibit hyperactivated immune systems and autoimmune diseases. |
PD-1 Antibody |
4065-01mg |
ProSci |
0.1 mg |
EUR 523.7 |
|
Description: PD-1 Antibody: Cell-mediated immune responses are initiated by T lymphocytes that are themselves stimulated by cognate peptides bound to MHC molecules on antig en-presenting cells (APC). T-cell activation is generally self-limited as activated T cells express receptors such as PD-1 (also known as PDCD-1) that mediate inhibitory signals from the APC. PD-1 can bind two different but related ligands, PDL-1 and PDL-2. Upon binding to either of these ligands, signals generated by PD-1 inhibit the activation of the immune response in the absence of "danger signals" such as LPS or other molecules associated with bacteria or other pathogens. Evidence for this is seen in PD1-null mice who exhibit hyperactivated immune systems and autoimmune diseases. |